Kistler-Tiffany Companies Position in Cvs Health (CVS) Raised by $374,088; Amazon.Com (AMZN) Holding Has Raised by American Research & Management

CVS Health Corporation (NYSE:CVS) Logo

Kistler-Tiffany Companies Llc increased its stake in Cvs Health Corp (CVS) by 25.53% based on its latest 2018Q3 regulatory filing with the SEC. Kistler-Tiffany Companies Llc bought 4,796 shares as the company’s stock declined 3.04% with the market. The institutional investor held 23,579 shares of the medical and nursing services company at the end of 2018Q3, valued at $1.86M, up from 18,783 at the end of the previous reported quarter. Kistler-Tiffany Companies Llc who had been investing in Cvs Health Corp for a number of months, seems to be bullish on the $87.67 billion market cap company. The stock increased 1.16% or $0.78 during the last trading session, reaching $67.79. About 9.70 million shares traded. CVS Health Corporation (NYSE:CVS) has risen 3.17% since February 13, 2018 and is uptrending. It has outperformed by 3.17% the S&P500. Some Historical CVS News: 13/03/2018 – AETNA HOLDERS OVERWHELMINGLY APPROVE PROPOSED PURCHASE BY CVS H; 22/03/2018 – Moody’s Affirms Three and Upgrades One Class of GMAC 1999-C2; 11/04/2018 – TABLE-CVS Bay 2687.T -2017/18 parent results; 16/04/2018 – CVS Health Teams Up with Job Corps to Enhance Workforce Development Opportunities for Aspiring Pharmacy Technicians; 06/03/2018 – S&PGR Affirms CVS ‘A-2’ Short-Term, Commercial Paper Ratings; 14/03/2018 – CVS and Walgreens hope that by helping people pick up their prescriptions, they can boost the rates of people taking their drugs, improve patient outcomes and ultimately lower costs; 02/05/2018 – CVS Health Still Sees Aetna Deal Closing in Second Half of 2018; 06/03/2018 – CVS Health readies one of the largest corporate bond sales on record; 19/03/2018 – CVS Health Launches Year Three of Be The First, Its $50 Million Initiative To Help Deliver a Tobacco-Free Generation; 24/05/2018 – Can CVS Health Buy BioPharmX Corporation? – CWEB.Com

American Research & Management increased its stake in Amazon.Com Inc (AMZN) by 31.73% based on its latest 2018Q3 regulatory filing with the SEC. American Research & Management bought 376 shares as the company’s stock declined 15.37% with the market. The institutional investor held 1,561 shares of the consumer services company at the end of 2018Q3, valued at $3.13 million, up from 1,185 at the end of the previous reported quarter. American Research & Management who had been investing in Amazon.Com Inc for a number of months, seems to be bullish on the $805.57 billion market cap company. The stock increased 0.12% or $1.99 during the last trading session, reaching $1640. About 3.53M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 41.49% since February 13, 2018 and is uptrending. It has outperformed by 41.49% the S&P500. Some Historical AMZN News: 26/04/2018 – Amazon is estimated to post first-quarter profit of $1.26 per share, down from the $1.48 per share reported a year ago, according to a Thomson Reuters consensus estimate; 27/04/2018 – Amazon raised the price for its Prime service from $99 to $119 per year – but will customers continue their subscriptions?; 05/03/2018 – Amazon Is Said to Expand Whole Foods Delivery to San Francisco; 07/03/2018 – Amazon has committed to roughly $22 billion in food purchases as it bulks up Whole Foods; 26/04/2018 – KIRO 7: Local bikini barista chain is subject of new Amazon Prime Video reality show, the story coming up; 02/04/2018 – Rep. Connolly: Trump blasts Amazon for hurting the postal service. Is that true?; 14/03/2018 – AMZN: On-site inspection on violation of antitrust law; 27/03/2018 – Casino’s Amazon Deal May Not Be Enough to See Off Leclerc Entry; 12/04/2018 – AMAZON.COM INC – AMAZON & RING HAVE DROPPED PRICE OF RING VIDEO DOORBELL TO $99.99; 17/05/2018 – Amazon’s 10-person board only has three women. That’s on par with the company’s peers. Via @ranimolla:

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: Alcoa, Cars.com, CVS, Electronic Arts, Halliburton, PNC, Salesforce, Walgreens, UnitedHealth and More – 24/7 Wall St.” on January 17, 2019, also Seekingalpha.com with their article: “CVS inks new PBM contract with Walmart – Seeking Alpha” published on January 18, 2019, Streetinsider.com published: “After-Hours Movers 1/31: (SYMC) (DGII) (CY) Higher; (CVS) (CI) (AMZN) (more…) – StreetInsider.com” on January 31, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS Health: This Despised Blue Chip Offers Market-Beating Total Return Potential – Seeking Alpha” published on February 12, 2019 as well as Fool.com‘s news article titled: “Better Buy: Walgreens Boots Alliance vs. CVS Health – Motley Fool” with publication date: January 19, 2019.

Since August 27, 2018, it had 0 insider purchases, and 9 selling transactions for $34.16 million activity. Brennan Troyen A sold 14,229 shares worth $1.17 million. MERLO LARRY J sold $11.49M worth of CVS Health Corporation (NYSE:CVS) on Tuesday, January 8. 4,426 shares were sold by Boratto Eva C, worth $354,080. On Thursday, November 29 Denton David M sold $2.02M worth of CVS Health Corporation (NYSE:CVS) or 25,159 shares. Another trade for 77,639 shares valued at $5.01M was made by Roberts Jonathan C on Monday, October 1. Bisaccia Lisa also sold $1.72M worth of CVS Health Corporation (NYSE:CVS) shares.

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 86 analyst reports since July 22, 2015 according to SRatingsIntel. Citigroup maintained the stock with “Neutral” rating in Monday, November 13 report. On Tuesday, November 7 the stock rating was maintained by Loop Capital with “Hold”. The rating was maintained by Jefferies on Wednesday, August 16 with “Hold”. RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) on Thursday, February 8 with “Buy” rating. The firm has “Buy” rating by Needham given on Tuesday, January 30. The firm earned “Overweight” rating on Thursday, March 10 by Barclays Capital. The company was maintained on Wednesday, January 17 by Robert W. Baird. The stock has “Neutral” rating by Citigroup on Monday, May 9. The rating was downgraded by Atlantic Securities to “Neutral” on Monday, February 6. The firm earned “Buy” rating on Tuesday, June 13 by Cowen & Co.

Investors sentiment increased to 1.12 in 2018 Q3. Its up 0.05, from 1.07 in 2018Q2. It increased, as 76 investors sold CVS shares while 459 reduced holdings. 144 funds opened positions while 456 raised stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Palouse Cap Mgmt accumulated 83,641 shares. Tiaa Cref Management Lc holds 6.38M shares. Beck Mack & Oliver Limited Company holds 11,626 shares or 0.03% of its portfolio. Broderick Brian C reported 66,926 shares. The Texas-based Adams Asset Advsrs Lc has invested 0.77% in CVS Health Corporation (NYSE:CVS). Reilly Advisors Lc invested in 0% or 100 shares. Meiji Yasuda Asset reported 33,587 shares. Checchi Cap Advisers Ltd Liability invested in 0.09% or 9,377 shares. Horizon Investments Ltd Liability has 19,423 shares for 0.05% of their portfolio. Metropolitan Life Insurance Ny holds 0.23% of its portfolio in CVS Health Corporation (NYSE:CVS) for 148,468 shares. 27,117 were reported by Meiji Yasuda Life Insur. Ipswich Investment Management Commerce Inc accumulated 2,853 shares. Lpl Lc has invested 0.07% in CVS Health Corporation (NYSE:CVS). Argyle Mgmt accumulated 1.25% or 42,510 shares. The Nebraska-based Pittenger And Anderson has invested 0% in CVS Health Corporation (NYSE:CVS).

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Livetradingnews.com which released: “Amazon.com, Inc. (NASDAQ:AMZN) stock continues to astound – Live Trading News” on February 06, 2019, also Nasdaq.com with their article: “Amazon (AMZN) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release – Nasdaq” published on January 24, 2019, Seekingalpha.com published: “Shareholder proposal targets Amazon’s Rekognition – Seeking Alpha” on January 17, 2019. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Nasdaq.com and their article: “After-Hours Earnings Report for January 31, 2019 : AMZN, AFL, EW, MCK, YUMC, AJG, SYMC, EMN, PKI, OTEX, CPT, FBHS – Nasdaq” published on January 31, 2019 as well as Seekingalpha.com‘s news article titled: “Amazon launches Live to take on QVC – Seeking Alpha” with publication date: February 08, 2019.

Among 57 analysts covering Amazon.com (NASDAQ:AMZN), 54 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 334 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by RBC Capital Markets on Friday, October 27. Loop Capital Markets initiated Amazon.com, Inc. (NASDAQ:AMZN) on Tuesday, September 12 with “Buy” rating. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by UBS on Friday, October 23. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, January 11 report. The rating was maintained by UBS on Friday, July 29 with “Buy”. The stock has “Buy” rating by Monness Crespi & Hardt on Wednesday, September 2. The firm has “Buy” rating given on Thursday, July 20 by Maxim Group. Tigress Financial maintained Amazon.com, Inc. (NASDAQ:AMZN) on Thursday, May 3 with “Buy” rating. On Tuesday, January 9 the stock rating was maintained by Piper Jaffray with “Buy”. JP Morgan maintained the shares of AMZN in report on Thursday, April 7 with “Overweight” rating.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart